Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides. - Wikidata - awgldk - TriplyDB

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

http://www.wikidata.org/entity/Q35865140

about

Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response Therapeutic Vaccine Strategies against Human Papillomavirus.TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.Peptide-based vaccines for cancer: realizing their potential.Model systems of human papillomavirus-associated disease.Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.

P2860

Q28484683-E731EB40-533D-49B1-AD80-75BE881B567C Q35201890-3FE9D583-E84A-49DC-B81F-CB4F2332CB3E Q35826752-2D71840D-9CF6-41D8-953A-DDD6CABBC0DB Q36245106-7E3C9065-44A4-4C21-B832-2356F21C9271 Q36341084-01C0C6E9-140C-4461-B3B5-0DD6C5BD79ED Q36711835-6B968398-7931-43D8-BC28-0CC95CCCFBD5 Q36987072-3350AF40-7AA0-4812-89FB-4F28F199B602 Q37340462-A28708D2-AF72-40A1-A267-71D4BF203FEC Q38604326-10C358DF-682D-4AA7-B128-8E7038E69692 Q38820109-5C9E6820-A576-420E-9171-6E74A466244A Q39995720-11A61C5A-B710-433D-AB63-2EF3F4A885C0 Q51050741-6C475BD9-882D-41EA-A6F9-8AF5931F27A1

P2860

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

http://www.wikidata.org/entity/Q35865140

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@ast

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@en

type

label

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@ast

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@en

prefLabel

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@ast

Rejection of large HPV-16 expr ...... sulated CTL/T helper peptides.

@en

P1433

Q35865140-2E953425-47B4-4CE3-9837-F7EE6B04DD22

P1476

Q35865140-B09F2C92-BED1-4D20-A4CC-F7D4F81AAAF7

P2093

Q35865140-66216EE6-1D9C-4D37-810F-6AA832F310BF

Q35865140-808B214A-C051-4B9F-AAE9-9FF3491D5E5B

Q35865140-89F3C7F4-CD49-44F4-AFE3-991508643A41

Q35865140-9B97FCC3-5BC0-4931-A2D2-6265A8D4A80F

Q35865140-A83C39EC-0D91-426A-B4CF-1E3E1F10C181

Q35865140-D4360B7E-0EFF-49FE-90A1-D36AFC4C007E

Q35865140-FF1CD4F3-BDE8-4F79-A495-05AF21DBD64F

P2860

Q35865140-0A321A81-9727-4732-A922-3A512E2E305C

Q35865140-1806601C-AE8E-437D-AE69-11DD5A747E95

Q35865140-2BAEA06A-D9F7-44A3-9C50-226692AB8807

Q35865140-3036B65C-2E9F-43CD-8E26-098551825375

Q35865140-3E2A5D17-57A4-4F7B-B963-0262CBF709FF

Q35865140-48080E3E-07DA-438A-A1FB-AA884FD32920

Q35865140-55456477-8BFB-4CD0-B032-E115CEF76A0F

Q35865140-572626D0-5B88-469D-9B0A-14F55D31E927

Q35865140-5EBAC9A1-783C-4D65-931B-D558AB607B22

Q35865140-A5544BDE-5AF6-4D7C-AE41-BDD9E207A84E

P2888

Q35865140-611A7232-F657-4F1F-B794-2F22F62126A5

P304

Q35865140-2D93B44C-D42E-4F29-9930-35CA683AD8EF

P31

Q35865140-56B3D85B-E06B-4C47-BBDE-2E348C4A6630

P356

Q35865140-211A0157-3DBB-4D11-8262-C53A6B61B78D

P478

Q35865140-3B020459-C729-4BC2-9554-1499C2548F72

P50

Q35865140-42522B93-971D-4DB8-9728-C3EFFB1B2756

Q35865140-8BD7A8AE-AB83-492D-ABD2-0654E0AC4388

P577

Q35865140-BF5A7581-49E8-4041-A247-405784E67D07

P5875

Q35865140-CFF144CF-30CB-4B60-9B20-061DFA0824CF

P6179

Q35865140-AB37AC68-D540-4596-8794-0BE76267715D

P698

Q35865140-7262DC95-66B2-4E14-AC17-2D48994691ED

P921

Q35865140-89224505-B48A-4B1A-A497-C3ED90D441FB

P932

Q35865140-99FBCA5A-4A11-4657-8893-449BF069DF7D

P356

P1433

Journal of Translational Medicine

P1476

Rejection of large HPV-16 expr ...... psulated CTL/T helper peptides

@en

P2093

Antar Fuentes-Ortega

http://www.w3.org/2001/XMLSchema#string

Bill Pohajdak

http://www.w3.org/2001/XMLSchema#string

Ella Korets-Smith

http://www.w3.org/2001/XMLSchema#string

Lisa Macdonald

http://www.w3.org/2001/XMLSchema#string

Marc Mansour

http://www.w3.org/2001/XMLSchema#string

Pirouz M Daftarian

http://www.w3.org/2001/XMLSchema#string

Robert G Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosenescence and vaccination.

Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.

Cost-effectiveness of a potential vaccine for human papillomavirus.

Tailoring cancer vaccines to the elderly: the importance of suitable mouse models.

Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine.

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

P2888

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-5-26

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Genevieve M Weir

P577

2007-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6280459

http://www.w3.org/2001/XMLSchema#string

P6179

1007310024

http://www.w3.org/2001/XMLSchema#string

P698

17555571

http://www.w3.org/2001/XMLSchema#string

P921

P932

1904180

http://www.w3.org/2001/XMLSchema#string